156 related articles for article (PubMed ID: 9289637)
1. Risk of breast cancer in carriers of BRCA gene mutations.
Orlando R
N Engl J Med; 1997 Sep; 337(11):787; author reply 789. PubMed ID: 9289637
[No Abstract] [Full Text] [Related]
2. Risk of breast cancer in carriers of BRCA gene mutations.
Birkmeyer JD; Welch HG
N Engl J Med; 1997 Sep; 337(11):787-8; author reply 789. PubMed ID: 9289638
[No Abstract] [Full Text] [Related]
3. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
[TBL] [Abstract][Full Text] [Related]
4. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
Rebbeck TR
J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
[TBL] [Abstract][Full Text] [Related]
6. Risk of breast cancer in carriers of BRCA gene mutations.
Whittemore AS
N Engl J Med; 1997 Sep; 337(11):788-9. PubMed ID: 9289641
[No Abstract] [Full Text] [Related]
7. BRCA genes--bookmaking, fortunetelling, and medical care.
Healy B
N Engl J Med; 1997 May; 336(20):1448-9. PubMed ID: 9145684
[No Abstract] [Full Text] [Related]
8. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
[TBL] [Abstract][Full Text] [Related]
9. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
10. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
11. Preventive gynecologic surgery for BRCA1/2 carriers--information for decision-making.
Quillin JM; Boardman CH; Bodurtha J; Smith T
Gynecol Oncol; 2001 Oct; 83(1):168-70. PubMed ID: 11585435
[No Abstract] [Full Text] [Related]
12. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
JAMA; 2000 Feb; 283(5):617-24. PubMed ID: 10665701
[TBL] [Abstract][Full Text] [Related]
13. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.
Grann VR; Jacobson JS; Sundararajan V; Albert SM; Troxel AB; Neugut AI
Cancer J Sci Am; 1999; 5(5):283-92. PubMed ID: 10526669
[TBL] [Abstract][Full Text] [Related]
14. Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.
Agnantis NJ; Paraskevaidis E; Roukos D
Ann Surg Oncol; 2004 Dec; 11(12):1030-4. PubMed ID: 15545500
[No Abstract] [Full Text] [Related]
15. Complex decision-making for BRCA1/2 carriers.
Matloff ET
Cancer J Sci Am; 1999; 5(5):266-8. PubMed ID: 10526666
[No Abstract] [Full Text] [Related]
16. Breast & ovarian cancer. Issues in risk assessment.
Caro SW
Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
[No Abstract] [Full Text] [Related]
17. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
18. Perspectives in the clinical management of BRCA mutations carriers.
Savarese A; Cognetti F
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):31-5. PubMed ID: 12585651
[TBL] [Abstract][Full Text] [Related]
19. Hereditary breast cancer.
Robson ME; Boyd J; Borgen PI; Cody HS
Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
[No Abstract] [Full Text] [Related]
20. Risk reduction works for BRCA mutation carriers--with heavy costs.
Vanchieri C
J Natl Cancer Inst; 2005 Jul; 97(14):1032-3. PubMed ID: 16030299
[No Abstract] [Full Text] [Related]
[Next] [New Search]